For Banting Scholar Dr. Brianne Kent, Research Is All about Rhythm

“The great thing about working with both patients and pre-clinical models is that the research truly is translational,” says Dr. Brianne Kent. “Understanding patients with Alzheimer disease helps me to ask the right questions, better inform study design, and delve into the mechanisms of the disease in a holistic way.” Dr. Kent, already a Killam Laureate and Michael Smith Foundation…
Read More
“If there is one thing we have to keep doing, it is explaining and making the case for research – of all types: basic and applied,” David Naylor, former University of Toronto president, told the packed room. He was addressing 200 of the nation’s scientists and researchers who had gathered last week at Metro Toronto Convention Centre to discuss the…
Read More
How do pathogenic bacteria manipulate host cells and cause disease? What molecular structures allow them to accomplish such feats? Here, at the Centre for Blood Research, Dr Natalie Strynadka’s laboratory and colleagues have used cryo-electron microscopy (cryo-EM) to visualize molecular details of the “nano-syringe” Salmonella uses to inject virulence proteins into eukaryotic host cells and cause disease. Their findings have…
Read More
Today Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus”) a specialty pharmaceutical company with expertise in drug delivery and clinical development, and the Centre For Drug Research and Development (“CDRD”), Canada’s national drug development and commercialization centre, announced a broad research collaboration to establish pre-clinical safety and efficacy of select cannabinoid-based therapeutics targeting neurological movement disorders including epilepsy, Multiple Sclerosis,…
Read More
Simon Fraser University researchers are investigating why some older Canadians living with multiple chronic health conditions maintain their resiliency. Professor Andrew Wister, director of SFU’s Gerontology Research Centre, is SFU’s principal investigator for the multi-university Canadian Longitudinal Study on Aging (CLSA). He leads one of 25 research teams benefiting from a share of $1.7 million in CLSA catalyst grants, funded…
Read More
Orkla Food Ingredients has inked a deal with Canada’s Renaissance BioScience to exclusively produce and sell its patent-pending, acrylamide-reducing yeast Acrylow in Nordic and Baltic countries. The ingredient will be rolled out in the third quarter of 2017. Acrylow allows manufacturers to achieve acrylamide reductions of between 50 and 95% depending on the dosage, process, and application.
Read More
To mark Canada’s 150th birthday, we are counting down to Canada Day with profiles of 150 noteworthy British Columbians. In 1971, Dr. Victor Ling was frustrated and full of doubt. It was an unusual period for Ling, who is known for his optimism about finding a cure for cancer. After getting his doctorate at the University of B.C., Ling was at Cambridge…
Read More
Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs) designed to “reboot” the body’s innate immune system, announces the peer-reviewed publication of proof of principle data in chronic obstructive pulmonary disease (COPD) in the journal, Respiratory Research. The study demonstrates success with Qu Biologics’ QBKPN SSI in reducing airway inflammation in a smoke-induced lung inflammation mouse model of…
Read More
A clinical trial for a type of brain stimulation therapy is underway at Surrey Memorial Hospital, and one expert says it can help youth suffering from addiction and depression, when all other options have failed. Faranak Farzan, an assistant professor of mechatronic engineering at Simon Fraser University, says transcranial magnetic stimulation — or TMS — is much less invasive  than other methods…
Read More